INDP icon

Indaptus Therapeutics
INDP

Overview Fund Activity

47 hedge funds and large institutions have $49.4M invested in Indaptus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+11
Holders Change %
+30.56%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
14
Reduced
9
Closed
5
Calls
$303K
Puts
$3M
Net Calls
-$2.7M
Net Calls Change
-$2.92M

Top Buyers

1
SFM
1
Sphera Funds Management
Israel
$2.69M
2
Mirae Asset Global Investments
2
Mirae Asset Global Investments
South Korea
$2.53M
3
HIIFS
3
Harel Insurance Investments & Financial Services
Israel
$2.71M
4
PM
4
Prosight Management
Texas
$3.54M
5
MIFH
5
Migdal Insurance & Financial Holdings
Israel
$3.17M

Top Sellers

1
ACA
1
Avoro Capital Advisors
New York
$3.56M
2
MIH
2
Meitav Investment House
Israel
$10.7M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
6CM
4
683 Capital Management
New York
$0
5
EIM
5
Essex Investment Management
Massachusetts
$1.23M
Name Holding Trade Value Shares
Change 		Shares
Change %
6CM
51
683 Capital Management
New York
– -$1.1M -67 Closed
PC
52
PA Capital
Virginia
– -$225K -14 Closed
MWNA
53
Marshall Wace North America
New York
– -$117K -7 Closed
PWM
54
PRW Wealth Management
Massachusetts
– -$28K -2 Closed
Citigroup
55
Citigroup
New York
– -$2K – –
WCM
56
Whitener Capital Management
North Carolina
– -$1K – –
1 2
3